Stefan Weber

Stefan Weber is a seasoned professional with a strong background in global health policy, business, and economics.

He holds a Master's Degree in Global Health Policy from the London School of Hygiene and Tropical Medicine, University of London, showcasing his expertise in health-related policies and strategies.

Additionally, Stefan studied Business and Economics at Universität St. Gallen and completed an exchange in an MBA program at Universidad Torcuato di Tella, highlighting his diverse educational background.

Throughout his career, Stefan has held prominent roles in various renowned organizations, including AstraZeneca, Amgen, Novartis, and Roche, where he demonstrated his leadership and strategic abilities.

At AstraZeneca, he serves as the Global Head of Policy, overseeing and shaping policy initiatives on a global scale to drive positive change and impact in the healthcare industry.

Previously, Stefan held key positions such as Director of Global Policy Center of Excellence and Director of Health Policy Europe and advanced markets at Amgen, showcasing his in-depth understanding of healthcare policies and market dynamics.

His tenure at Novartis saw him spearheading crucial roles like Head of Global Pricing & Value Policy, Head of Pricing & Payer initiatives in Oncology for Emerging Growth Markets, and Market Access Manager for Latin America, reflecting his proficiency in pricing strategies and market access.

During his time at Roche, Stefan excelled in roles including Regional Market Access Manager for Latin America, Task-Force Leader for Bonviva & Xenical in Latin America, Product Manager for the Metabolism Line in Argentina, and Analyst in Business Intelligence, showcasing his versatility and expertise across different domains.

With a solid foundation in finance from his experience as a Finance Manager at Papelera San Andrés de Giles, Stefan possesses a well-rounded skill set that spans policy development, market access, pricing strategies, and business intelligence.

Stefan Weber's wealth of experience and diverse expertise make him a valuable asset in the healthcare and pharmaceutical industry, driving innovation, policy advancements, and strategic decision-making.

His academic achievements, coupled with his extensive professional experience in major healthcare organizations, position him as a respected figure in the field of global health policy, business, and economics.